Virulence and pathogenicity of group B Streptococcus: Virulence factors and their roles in perinatal infection

被引:0
|
作者
Megli, Christina J. [1 ,2 ]
Carlin, Sophia M. [3 ]
Giacobe, Elizabeth J. [3 ]
Hillebrand, Gideon H. [3 ]
Hooven, Thomas A. [3 ,4 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Obstet & Gynecol, Pittsburgh, PA USA
[2] UPMC Med Ctr, Magee Womens Res Inst, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA
[4] UPMC Childrens Hosp Pittsburgh, RK Mellon Inst Pediat Res, Pittsburgh, PA 15224 USA
关键词
Group B <italic>streptococcus</italic>; <italic>Streptococcus agalactiae</italic>; neonatology; sepsis; pneumonia; meningitis; CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; ALTERNATIVE COMPLEMENT PATHWAY; SIGNAL-TRANSDUCTION SYSTEM; SIALIC-ACID; BETA-HEMOLYSIN/CYTOLYSIN; C5A PEPTIDASE; MOLECULAR CHARACTERIZATION; STAPHYLOCOCCUS-AUREUS; RESPONSE REGULATOR; EPITHELIAL-CELLS;
D O I
10.1080/21505594.2025.2451173
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review summarizes key virulence factors associated with group B Streptococcus (GBS), a significant pathogen particularly affecting pregnant women, fetuses, and infants. Beginning with an introduction to the historical transition of GBS from a zoonotic pathogen to a prominent cause of human infections, particularly in the perinatal period, the review describes major disease manifestations caused by GBS, including sepsis, meningitis, chorioamnionitis, pneumonia, and others, linking each to specific virulence mechanisms. A detailed exploration of the genetic basis for GBS pathogenicity follows, emphasizing the roles of capsules in pathogenesis and immune evasion. The paper also examines the molecular structures and functions of key GBS surface proteins, such as pili, serine-rich repeat proteins, and fibrinogen-binding proteins, which facilitate colonization and disease. Additionally, the review discusses the significance of environmental sensing and response systems, like the two-component systems, in adapting GBS to different host environments. We conclude by addressing current efforts in vaccine development, underscoring the need for effective prevention strategies against this pervasive pathogen.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] A type VII secretion system in Group B Streptococcus mediates cytotoxicity and virulence
    Spencer, Brady L.
    Tak, Uday
    Mendonca, Jessica C.
    Nagao, Prescilla E.
    Niederweis, Michael
    Doran, Kelly S.
    PLOS PATHOGENS, 2021, 17 (12)
  • [42] POSSIBLE VIRULENCE MARKER FOR STREPTOCOCCUS-AGALACTIAE (LANCEFIELD GROUP-B)
    OREFICI, G
    RECCHIA, S
    GALANTE, L
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (02) : 302 - 305
  • [43] Epidemiology, Antimicrobial Resistance, and Virulence Determinants of Group B Streptococcus in an Australian Setting
    Jones, Sandra
    Newton, Peter
    Payne, Matthew
    Furfaro, Lucy
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [44] LuxS and expression of virulence factors in Streptococcus intermedius
    Pecharki, D.
    Petersen, F. C.
    Scheie, A. Aa.
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2008, 23 (01): : 79 - 83
  • [45] The virulence factors and pathogenic mechanisms of Streptococcus pyogenes
    Terao, Yutaka
    JOURNAL OF ORAL BIOSCIENCES, 2012, 54 (02): : 96 - 100
  • [46] Molecular analysis of virulence factors of Streptococcus pneumoniae
    Mitchell, TJ
    Alexander, JE
    Morgan, PJ
    Andrew, PW
    JOURNAL OF APPLIED MICROBIOLOGY, 1997, 83 : S62 - S71
  • [47] Genotypes and Virulence Genes in Group B Streptococcus Isolated in the Maternity Hospital, Kuwait
    Udo, Edet E.
    Boswihi, Samar S.
    Al-Sweih, Noura
    MEDICAL PRINCIPLES AND PRACTICE, 2013, 22 (05) : 453 - 457
  • [48] Virulence factors and epidemiological markers of Streptococcus pyogenes
    Loubinoux, J
    Mihaila-Amrouche, L
    Bouvet, A
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 : S17 - S18
  • [49] Pathogenicity and virulence of Helicobacter pylori: A paradigm of chronic infection
    Clyne, Marguerite
    Croinin, Tadhg O.
    VIRULENCE, 2025, 16 (01)
  • [50] INVIVO ASSESSMENT OF THE VIRULENCE FACTORS OF GROUP-B STREPTOCOCCI
    SHIGEOKA, AO
    SANTOS, JI
    HILL, HR
    CLINICAL RESEARCH, 1980, 28 (01): : A112 - A112